Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 71% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 5 institutions in 3 countries.
Junyan LiuSchool of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, Engineering Research Center of Starch and Vegetable Protein Processing Ministry of Education, South China University of Technology, Guangzhou, Guangdong, China.
Xin LinSchool of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, Engineering Research Center of Starch and Vegetable Protein Processing Ministry of Education, South China University of Technology, Guangzhou, Guangdong, China.
Thanapop SoteyomeHome Economics Technology, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand.
Yanrui YeSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong, China.
Dingqiang ChenDepartment of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Ling YangDepartment of Laboratory Medicine, The First Affiliated Hospital of Guangzhou University, Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhenbo XuSchool of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, Engineering Research Center of Starch and Vegetable Protein Processing Ministry of Education, South China University of Technology, Guangzhou, Guangdong, China.ORCID 0000-0003-2865-2441
Rajamangala University of Technology Phra Nakhon · THSouth China University of Technology · CNGuangzhou University · CNZhongkai University of Agriculture and Engineering · CNZhujiang Hospital · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Since antimicrobial resistance, especially β-lactam resistance genes were common in clinical
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A strategy design based on antibiotic‑resistance and plasmid replicons genes of clinical Escherichia coli strains. · full record | OpenQuestion